Literature DB >> 2327636

Single-breath carbon monoxide diffusing capacity prediction equations from a Mediterranean population.

J Roca1, R Rodriguez-Roisin, E Cobo, F Burgos, J Perez, J L Clausen.   

Abstract

Because of unanswered questions about prediction equations for the single-breath carbon monoxide diffusing capacity (DLCO) and as part of a larger collaborative project, standardized DLCO measurements were carried out in a selected sample of 361 healthy nonsmoking volunteers (194 men and 167 women) living in the Barcelona metropolitan area (Spain). Except for the test FIO2 (0.18), the study essentially followed the American Thoracic Society (ATS) and European Community for Coal and Steel (ECCS) recommendations for standardizing the methodology of measuring DLCO. Prediction equations for ages 20 through 70 were calculated separately for both sexes. Simple linear equations using age, height, and body weight as independent variables predicted the DLCO indices (DLCO, VA, and DL/VA) as well as more complex equations. In addition, a complete analysis of the residuals (predicted measured values) showed that the assumptions of the multiple regression analysis (independence, homoscedasticity and Gaussian distribution of residuals) were fulfilled using simple linear equations. Correction for the instrumental and anatomic dead spaces decreased the DLCO an average of 4.7%. The standard error of estimates was lower than those reported from other series in the literature. The predicted values from this study were lower than those reported by some investigators and were in reasonable agreement with other studies. A portion but not all of the differences could be explained on the basis of recognized differences in testing methodology. The results of this study may be of value to clinical laboratories seeking predictive equations for DLCO most appropriate for their testing methodology and patient population, and may assist in the resolution of some controversies regarding differences among predictive equations for DLCO.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2327636     DOI: 10.1164/ajrccm/141.4_Pt_1.1026

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  30 in total

1.  ICAM-1, ICAM-2 and ICAM-3 in the sera of patients with idiopathic pulmonary fibrosis.

Authors:  Pelagia G Tsoutsou; Konstantinos I Gourgoulianis; Efthymia Petinaki; Maria Mpaka; Smaragda Efremidou; Antonios Maniatis; Pashalis Adam Molyvdas
Journal:  Inflammation       Date:  2004-12       Impact factor: 4.092

2.  Sex differences in function and structure of the quadriceps muscle in chronic obstructive pulmonary disease patients.

Authors:  Pilar Ausín; Juana Martínez-Llorens; Marina Sabaté-Bresco; Carme Casadevall; Esther Barreiro; Joaquim Gea
Journal:  Chron Respir Dis       Date:  2016-12-06       Impact factor: 2.444

3.  Expiratory muscle endurance in chronic obstructive pulmonary disease.

Authors:  A Ramírez-Sarmiento; M Orozco-Levi; E Barreiro; R Méndez; A Ferrer; J Broquetas; J Gea
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

4.  Pulmonary complications after long term amiodarone treatment.

Authors:  J Roca; M Heras; R Rodriguez-Roisin; J Magriñà; A Xaubet; G Sanz
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

5.  Aerosolised ribavirin in patients with advanced cryptogenic fibrosing alveolitis: a pilot study.

Authors:  C Agustí; A Xaubet; E Ballester; A Alarcón; C Picado
Journal:  Thorax       Date:  1993-01       Impact factor: 9.139

6.  Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression.

Authors:  M Molina-Molina; A Xaubet; X Li; A Abdul-Hafez; K Friderici; K Jernigan; W Fu; Q Ding; J Pereda; A Serrano-Mollar; A Casanova; E Rodríguez-Becerra; F Morell; J Ancochea; C Picado; B D Uhal
Journal:  Eur Respir J       Date:  2008-05-28       Impact factor: 16.671

7.  Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up.

Authors:  C Agustí; A Xaubet; J Roca; A G Agustí; R Rodriguez-Roisin
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

8.  Computed tomography-guided bronchoalveolar lavage in idiopathic pulmonary fibrosis.

Authors:  C Agusti; A Xaubet; P Luburich; M C Ayuso; J Roca; R Rodriguez-Roisin
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

9.  Isolated DLco/VA reduction in systemic sclerosis patients: a new patient subset?

Authors:  Patricia Corzo; Anna Pros; Juana Martinez-Llorens; Luis Molina; Stephanie Fenxi Ling; Eva Balcells
Journal:  Clin Rheumatol       Date:  2018-10-27       Impact factor: 2.980

10.  Analysis of clinical symptoms, radiological changes and pulmonary function data 4 months after COVID-19.

Authors:  Gonzalo Labarca; Mario Henríquez-Beltrán; Jaime Lastra; Daniel Enos; Faryd Llerena; Igor Cigarroa; Liliana Lamperti; Valeska Ormazabal; Carlos Ramirez; Eric Espejo; Nicole Canales; Fabiola Fuentes; Gloria Horta; Sebastian Fernandez-Bussy; Estefania Nova-Lamperti
Journal:  Clin Respir J       Date:  2021-06-29       Impact factor: 1.761

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.